Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Share Option Schemes

4 Oct 2010 11:58

RNS Number : 7994T
Imaginatik PLC
04 October 2010
 



4 October 2010

Imaginatik Plc

("Imaginatik" or the "Company")

Share Option Schemes

 

Imaginatik plc (AIM:IMTK), a leading provider of idea management software and innovation consultancy, announces that on 30 September 2010, the remuneration committee of the Board approved the issue of share options to all employees, including directors, and also approved the re-basing of the exercise price of all subsisting share options in issue at that date, to 2.55p per share. This provides both the senior management team and employees an appropriate and effective incentive for the future.

 

The Company has two share option schemes in place. The Imaginatik Plc Enterprise Management Incentive Scheme (the "Share Option Scheme") and the Imaginatik 2006 Stock Option Plan (the "Stock Option Plan"). There are 17,695,882 share options over ordinary shares of 0.0625p each outstanding under the Share Option Scheme and 8,050,000 share options over ordinary shares of 0.0625p each outstanding under the Stock Option Plan. In addition, there are 4,693,463 share options outstanding under the unapproved share option scheme.

 

No other changes to the share option deeds, dated 11 December 2006, have been made.

 

Options have also been granted to the following directors of the Company, these options are included in the outstanding options noted above:

 

 

Director

Options granted

Total number of share options

Matt Cooper

2,125,000

3,125,000

Shawn Taylor

1,700,000

6,200,000

Andrew Wainwright

1,500,000

3,750,000

 

All the Options have been granted at an exercise price of 2.55 pence per share and are exercisable from 30 September 2012 to 30 September 2013.

 

Matt Cooper, Executive Chairman commented,"It remains the view of the Board that the rebasing of the share options to this level represents the best means by which we can ensure that all of our talented employees remain well incentivised. Share options are a crucial tool in the motivation of all of our employees, furthermore I believe that the shareholders will enjoy benefits earlier if all of our personnel have a more achievable interest in the success of the business"

 

For further information please contact:

 

Imaginatik plc

Tel: 020 7917 2975

Matthew Cooper, Chairman / Shawn Taylor, CFO

Arbuthnot Securities Limited

Tel: 020 7012 2000

Tom Griffiths

Threadneedle Communications

Tel: 020 7653 9850

Caroline Evans-Jones / Hilary Millar

 

About Imaginatik

 

Imaginatik provides Innovation and idea management solutions to companies such as The Chubb Group of Insurance Companies, Boeing, Pfizer, Xerox, Goodyear and Cargill. Few companies possess the internal capability to consistently generate fresh ideas, identify those worth pursuing and reliably transform them into real, value-enhancing assets. This is Imaginatik's area of expertise.

 

Imaginatik provides customers with strategic consulting, the award-winning Idea Central technology solution and an experienced, results-oriented innovation consulting team.

 

Imaginatik is a public company whose shares are traded on the AIM market of the London Stock Exchange (LSE:IMTK.L) and a World Economic Forum Technology Pioneer with offices in Boston, MA, and London. In 2009, Imaginatik was named as one of the 500 fastest growing technology companies in the EMEA region by Deloitte.

 

For more information visit www.imaginatik.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFEIIDLSIII
Date   Source Headline
9th Jun 201710:54 amRNSProposed Placing
27th Apr 20177:00 amRNSChange of Registered Office
25th Apr 20177:00 amRNSTrading Update
24th Apr 20178:16 amRNSHolding(s) in Company
27th Feb 201710:35 amRNSHolding(s) in Company
14th Dec 20169:31 amRNSHolding(s) in Company
9th Dec 201611:47 amRNSHolding(s) in Company
6th Dec 20167:00 amRNSHalf-year Report
25th Nov 20169:56 amRNSHolding(s) in Company
24th Nov 20167:00 amRNSTrading Update and Notice of Results
13th Sep 20162:29 pmRNSResult of AGM
13th Sep 20167:00 amRNSGrant of Options
17th Aug 20167:00 amRNSFinal Results
10th Aug 20163:21 pmRNSHolding(s) in Company
21st Jul 20164:46 pmRNSHolding(s) in Company
28th Jun 201612:12 pmRNSHolding(s) in Company
27th Jun 201611:45 amRNSHolding(s) in Company
24th Jun 20167:00 amRNSResult of Open Offer and Total Voting Rights
16th Jun 201610:35 amRNSHolding(s) in Company
13th Jun 201611:20 amRNSResult of General Meeting
25th May 20167:00 amRNSFundraising
17th May 201612:26 pmRNSFunding Update
17th May 201610:51 amRNSPress Speculation
29th Apr 20169:09 amRNSHolding(s) in Company
28th Apr 201610:54 amRNSHolding(s) in Company
27th Apr 20169:04 amRNSHolding(s) in Company
13th Apr 20161:36 pmRNSHolding(s) in Company
12th Apr 201610:18 amRNSHolding(s) in Company
6th Apr 20164:51 pmRNSHolding(s) in Company
6th Apr 20161:23 pmRNSPress Speculation
9th Mar 20167:00 amRNSTrading Update
26th Jan 201610:03 amRNSHolding(s) in Company
21st Jan 20162:51 pmRNSHolding(s) in Company
5th Jan 20167:00 amRNSDirector Loan
17th Dec 20158:20 amRNSHolding(s) in Company
15th Dec 20157:00 amRNSGrant of Options
10th Dec 20157:00 amRNSHalf Yearly Report
13th Nov 20153:35 pmRNSWarrant Exercise
9th Nov 20153:57 pmRNSTrading update
6th Nov 20154:13 pmRNSHolding(s) in Company
23rd Sep 20153:07 pmRNSResult of AGM
16th Sep 20157:00 amRNSDirector Loan
14th Sep 20155:33 pmRNSHolding(s) in Company
1st Sep 20154:34 pmRNSNotice of AGM
1st Sep 20152:23 pmRNSHolding(s) in Company
24th Aug 20157:00 amRNSHolding(s) in Company
10th Aug 20152:20 pmRNSHolding(s) in Company
6th Aug 20151:41 pmRNSHolding(s) in Company
3rd Aug 201512:05 pmRNSHolding(s) in Company
30th Jul 20151:16 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.